240 related articles for article (PubMed ID: 27581495)
1. Methylparaben stimulates tumor initiating cells in ER+ breast cancer models.
Lillo MA; Nichols C; Perry C; Runke S; Krutilina R; Seagroves TN; Miranda-Carboni GA; Krum SA
J Appl Toxicol; 2017 Apr; 37(4):417-425. PubMed ID: 27581495
[TBL] [Abstract][Full Text] [Related]
2. Bisphenol A Induces Sox2 in ER
Lillo MA; Nichols C; Seagroves TN; Miranda-Carboni GA; Krum SA
Horm Cancer; 2017 Apr; 8(2):90-99. PubMed ID: 28244015
[TBL] [Abstract][Full Text] [Related]
3. Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells.
Sonthithai P; Suriyo T; Thiantanawat A; Watcharasit P; Ruchirawat M; Satayavivad J
J Appl Toxicol; 2016 Jun; 36(6):790-801. PubMed ID: 26234195
[TBL] [Abstract][Full Text] [Related]
4. Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.
Ma R; Karthik GM; Lövrot J; Haglund F; Rosin G; Katchy A; Zhang X; Viberg L; Frisell J; Williams C; Linder S; Fredriksson I; Hartman J
J Natl Cancer Inst; 2017 Mar; 109(3):1-14. PubMed ID: 28376210
[TBL] [Abstract][Full Text] [Related]
5. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
6. Progression of breast cancer cells was enhanced by endocrine-disrupting chemicals, triclosan and octylphenol, via an estrogen receptor-dependent signaling pathway in cellular and mouse xenograft models.
Lee HR; Hwang KA; Nam KH; Kim HC; Choi KC
Chem Res Toxicol; 2014 May; 27(5):834-42. PubMed ID: 24684733
[TBL] [Abstract][Full Text] [Related]
7. 4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway.
Lee HR; Choi KC
Toxicology; 2013 Feb; 304():13-20. PubMed ID: 23219593
[TBL] [Abstract][Full Text] [Related]
8. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
9. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of silver nanoparticles on proliferation of estrogen-dependent MCF-7/BUS human breast cancer cells induced by butyl paraben or di-n-butyl phthalate.
Roszak J; Smok-Pieniążek A; Domeradzka-Gajda K; Grobelny J; Tomaszewska E; Ranoszek-Soliwoda K; Celichowski G; Stępnik M
Toxicol Appl Pharmacol; 2017 Dec; 337():12-21. PubMed ID: 29074358
[TBL] [Abstract][Full Text] [Related]
11. IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
Hu H; Sun J; Wang C; Bu X; Liu X; Mao Y; Wang H
Biochem Biophys Res Commun; 2017 Apr; 485(3):643-650. PubMed ID: 28216163
[TBL] [Abstract][Full Text] [Related]
12. Benzophenone-1 and nonylphenol stimulated MCF-7 breast cancer growth by regulating cell cycle and metastasis-related genes via an estrogen receptor α-dependent pathway.
In SJ; Kim SH; Go RE; Hwang KA; Choi KC
J Toxicol Environ Health A; 2015; 78(8):492-505. PubMed ID: 25849766
[TBL] [Abstract][Full Text] [Related]
13. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
14. DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor-Positive Breast Cancer Following Endocrine Therapy.
Peiffer DS; Wyatt D; Zlobin A; Piracha A; Ng J; Dingwall AK; Albain KS; Osipo C
Cancer Res; 2019 Oct; 79(19):4965-4977. PubMed ID: 31387918
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
16. The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer.
Bean JR; Hosford SR; Symonds LK; Owens P; Dillon LM; Yang W; Shee K; Schwartz GN; Marotti JD; Muller KE; Rosenkranz KM; Barth RJ; Chen VS; Agarwal VR; Miller TW
Breast Cancer Res Treat; 2015 Jan; 149(1):69-79. PubMed ID: 25491778
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and application of 131I-fulvestrant as a targeted radiation drug for endocrine therapy in human breast cancer.
Yin G; Zeng B; Peng Z; Liu Y; Sun L; Liu C
Oncol Rep; 2018 Mar; 39(3):1215-1226. PubMed ID: 29328488
[TBL] [Abstract][Full Text] [Related]
18. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
19. Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells.
Kurebayashi J; Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T
Cancer Sci; 2017 May; 108(5):918-930. PubMed ID: 28211214
[TBL] [Abstract][Full Text] [Related]
20. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC
Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]